JENNIFER WEBER: Open Payments
NPI 1336281609 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 8 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $152 |
| REVANCE THERAPEUTICS, INC. | 4 | $148 |
| Galderma Laboratories, L.P. | 2 | $103 |
| Novo Nordisk Inc | 1 | $20 |
Products named: Xeomin, DAXXIFY, DYSPORT, Ozempic.
Industry payments across MS — which companies pay providers there.
